FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
about
A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intentEfficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer.Adjuvant chemo-radiotherapy in the "sandwich" method for high risk endometrial cancer--a review of literature.Controversies in the management of endometrial carcinoma: an update.Combined chemotherapy and radiation improves survival for node-positive endometrial cancer.The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.Current treatment strategies for endometrial cancer.Endometrial carcinoma: the current role of adjuvant radiation.Adjuvant therapy for endometrial cancer.No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer.Problematic issues in the staging of endometrial, cervical and vulval carcinomas.Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
P2860
Q30299971-35EE48EE-63C2-45E3-9B06-B4FBFE5FDC7FQ34330331-356668EE-3C8B-4778-A18E-6058C4CC21E4Q35024980-67D219BF-FD0A-4BD5-8B44-A744D4EA6E25Q35649042-41AABB28-0317-4217-AB79-DF7BCE81AB65Q35775512-C873BC05-FC0E-4C54-AC41-3181B77157D1Q35837883-81932BC1-0458-4F22-8E6A-A0C21774290AQ36343110-4CF31716-46B5-4A6A-828C-C660AF649191Q36611027-80C48A19-55CD-4955-994F-C8B7FB18BDB8Q37202781-619BD764-D8F5-44E7-AF9C-06C32CDB5249Q37410937-04EDA527-2B1C-414B-B8FD-2D451C6ECE40Q37717743-ED359B59-B3CE-4B98-AE90-800A255D21EEQ37774355-E5BB1AB5-AF4F-4861-854B-36BB884030CAQ38067442-2DB9A0B1-1405-41D3-89E5-0367237539FBQ41721420-0197891F-E128-44E9-92A0-D22812612F84Q53204711-8826FB3B-FC6A-40CB-8FF3-3048A6DB439A
P2860
FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@ast
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@en
type
label
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@ast
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@en
prefLabel
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@ast
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@en
P2093
P356
P1433
P1476
FIGO stage IIIC endometrial ca ...... ng adjuvant radiation therapy.
@en
P2093
P304
P356
10.1006/GYNO.1999.5569
P407
P577
1999-11-01T00:00:00Z